- Framework of problems / Objective
- Financial conflicts of interest of review authors
- Association between author conflicts of interest and industry-sponsorship with the favorability of outcomes of systematic reviews focusing on treatments of erectile dysfunction
Ref ID | 795 |
First Author | A. Corcoran |
Journal | ANDROLOGY |
Year Of Publishing | 2021 |
URL | https://onlinelibrary.wiley.com/doi/full/10.1111/andr.13064 |
Keywords |
Transparency Allegiance Sponsorship bias Endocrinology Disclosure Non-Cochrane reviews |
Problem(s) |
Conflict of interest statement or disclosures for review authors missing Financial conflicts of interest of review authors |
Number of systematic reviews included | 24 |
Summary of Findings | From 23 included systematic reviews of treatment interventions for erectile dysfunction indexed in PubMed and Embase between September 1, 2016, and June 2, 2020. Nineteen authors (13.8%) were found to have conflicts of interest (disclosed, undisclosed, or both). No authors completely disclosed all conflicts. Nine reviews (37.5%) contained at least one author with conflicts of interest; of which eight reported narrative results favouring the treatment group, and seven reported conclusions favouring the treatment group. Of the 15 (62.5%) reviews without a conflicted author, 11 reported results favouring the treatment group, and 12 reported conclusions favouring the treatment group. |
Did the article find that the problem(s) led to qualitative changes in interpretation of the results? | No |
Are the methods of the article described in enough detail to replicate the study? | No |